Dermapharm Holding
DMP.DE Mid CapHealthcare · Drug Manufacturers - Specialty & Generic
Aggiornato: May 2, 2026, 22:05 UTC
Metriche Chiave
Analisi della Valutazione
Informazioni sull'Azienda
Dermapharm Holding Stock at a Glance
Dermapharm Holding (DMP.DE) is currently trading at 46,35 € with a market capitalization of 2,1 Mrd. €. The trailing P/E ratio stands at 21.56x, with a forward P/E of 16.12x. The 52-week range spans from 31,70 € to 47,25 €; the current price is 1.9% below the yearly high. Year-over-year revenue growth stands at +1.4%. The net profit margin stands at 11.24%.
💰 Dividendo
Dermapharm Holding pays an annual dividend of 0,88 € per share, representing a yield of 1.9%. The payout ratio stands at 41.86%.
📊 Raccomandazioni degli Analisti
4 analysts rate Dermapharm Holding (DMP.DE) on consensus: None. The average price target is 43,50 €, implying -6.15% from the current price. Analyst price targets range from 34,00 € to 48,00 €.
Tesi di Investimento: Punti di Forza e Debolezze
- High return on equity (20.22% ROE)
- High gross margin of 64.98% — indicates pricing power
- Positive free cash flow
- –High leverage (D/E 153.15)
Panoramica Tecnica
Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).
Profilo di Rischio
The data points to relatively defensive market behavior, higher leverage relative to equity.
Dati di Trading
💵 Info Dividendo
Azioni Correlate nello Stesso Settore
Where can I buy Dermapharm Holding?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
